Adaptimmune Therapeutics PLC (NAS:ADAP)
$ 1.19 0.04 (3.48%) Market Cap: 304.12 Mil Enterprise Value: 172.19 Mil PE Ratio: 0 PB Ratio: 7.00 GF Score: 66/100

Adaptimmune Therapeutics PLC (ADAP) Transcripts

  • 1